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summary 
Native Americans use a wide range of plants medicinally. Many of these 
plants have profound meaning to their users. Does this mean, as some assert, 
that tribal medicine is “all placebo”? Since the essential character of meaning 
is the arbitrariness of the sign, then insofar as this medicine is symbolic, the 
plants used medicinally will be a random representation of plants avaiiable in 
nature. Several regression analyses of plants used by native Americans on 
plants available to them indicate substantial selectivity in plant use. Native 
American medical ethnobotany is not only placebo medicine. 
Many investigators over the past century have commented on the medi- 
cal value of the native American pharmacopoeia. Yet anyone who has 
worked for long with the materials of ethnobotany occasionally finds himself 
confronting curious and disquieting anomalies. Consider the following items, 
culled from a large listing of native American medical ethnobotany (Moerman, 
1977): 
(1) While Pauite and Shoshone are reported to use a decoction of the 
root of Berberis repens (barberry) as an antidiarrheal (Train et al., 1941, 
p. 52), the Ramah Navaho use the same decoction as a laxative (Vestal, 
1952, p. 28). 
(2) While Creek Indians are reported to use a decoction of leaves of 
Gnaphalium oftusifolium (Everlasting) internally and externally as a sedative 
to help the elderly sleep (Swanton, 1928, p. 661), the Fox smudge the leaves 
of the plant to revive unconscious individuals (Smith, 1928, pp. 214 - 5). 
(3) While Mohegan Indians reportedly used an infusion of blossoms of 
AHumufus lupulus (hops) as a sedative to relieve nervous tension (Tantaquid- 
geon, 1972, p. 72), the Delaware of Oklahoma use a decoction of leaves of 
the same plant as a stimulant (Tantaquidgeon, 1942, p. 76). 
(4) While Pauite Indians reportedly use a decoction of Lygodesmia 
spinosa (Indian gum plant) as an emetic (Train et al., 1941, pp. 102 - 3), the 
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neighboring Shoshone are reported by the same authors to use the same 
medication as an antiemetic (ibid., pp. 102 - 3). 
More similar cases could be cited. Recognizing that the part of the plant 
used, the way it is prepared, the dosage, the length of administration, and 
other matters greatly affect the physiological activity of plant drugs only 
marginally diminishes our concern that these cases indicate that the phar- 
macology of the medication might be a secondary matter in native therapy. 
We are all aware that the conceptualizations of doctors and patients are 
important factors in the effectiveness of any medical or surgical procedure. 
The pervasive placebo effect, which encumbers biomedicine with the necessity 
of double blind procedures, is a powerful human force (for a recent review 
of the theoretical and philosophical implications of such forms of symbolic 
healing, see Moerman, 1979). 
Our awareness of these symbolic factors in medicine, coupled with the 
recognition of anomalies like those listed above, suggest a disconcerting 
hypothesis, that native American medicine is substantially based on general 
factors, is “all placebo”. Some authors flatly assert this; Adler and Hammet, 
for instance, note “it is generally agreed that the history of medicine up until 
the last 100 - 150 years has been the history of this pervasive placebo effect” 
(Adler and Hammet, 1973, p. 595). 
Counter arguments can, of course, be easily made by showing, through 
pharmacological trials, that certain tribal medications do have appropriate 
therapeutic action. Solecki’s famous account of Middle Paleolithic medicinal 
plants at Shanidar is a helpful case (Solecki, 1975). 
I propose an additional approach to the problem. Were native American 
medicine “all placebo”, then the medications used (primarily botanicals) 
would be used because of their “meanings” or their “symbolic values”. 
Since the essential character of “meaning” is the arbitrariness of symbol, it 
seems reasonable to assert that, insofar as native American medicine is 
“symbolic”, the plants used medicinally will be a random representation of 
plants in nature. This paper will report a test of that hypothesis. 
Data come primarily from two sources. Medical information comes 
from a computerized database of native American Medical Ethnobotany 
(AME). Included in this database are 1288 different plant species from 531 
different genera and 118 different families used medically by 48 different 
cultures in 4869 different ways (Moerman, 1977). Botanical information 
comes from another computerized database, the Species Name List of Flora 
North America (FNA) which lists 16270 species from 2352 genera in 232 
families*. A published version of this list has just appeared under the title 
*The FNA Checklist was manipulated to obtain a list of numbers of genera and 
species per family for North America and four selected regions. These data, and data for 
the remaining 13 regions coded in FNA will be published separately. These data are, of 
course, provisional; but since taxonomy is as much art as science, it seems unlikely that, 
short of major changes in the contemporary approach to classification, substantial shifts 
in these varying generic and specific frequencies are in the offing. 
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A Provisional Checklist of Species for Flora North America (Shetler and 
Skog, 1978). By appropriate manipulation of these two databases, the 
author was able to test the hypothesis that, in North America as a whole, 
and in four selected North American regions (North Central, Southwest, 
Intermountain, and Western Canada), the number of genera and species per 
family present in the region according to FNA could account for the number 
of items from that family in AME (see Table 1). The statistical model used 
was multiple linear regression. A regression model tests the hypothesis that 
there is a functional relationship between two variables. If medicinal use 
is a function of generic and specific availability, a regression would show 
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In the five selected regions, the number of AME items per family was 
regressed on the number of FNA genera and species per family (see Table 2). 
The results of these regressions are quite variable. Multiple correlation (r) 
varies from a high of 0.854 in the Southwest to a low of 0.445 in Western 
Canada, while for all of North America the figure is 0.781. The coefficient 
of determination (r*) for North America is 0.611; this can be read as saying 
that 61% of the variance in the number of genera used medicinally per family 
can be explained by the number of available genera and species per family. 
TABLE 2 
Multiple regressions: number of medicinal items per family regressed on number of genera 
and number of species, for North America and four selected regions (N = 232 in each case) 
Region Multiple Coef. of Constant Regression coefficients Residuals 
correlation determination -- 
(r) (r2) 
Genera Species S* K** 
NA 0.781 0.611 0.428 1.025 0.143 0.275 38,457 
NC 0.694 0.421 1.15 0.327 0.131 1.297 26.329 
SW 0.854 0.730 -1.22 1.59 -0.134 ---1.876 51.998 
IM 0.805 0.648 -0.652 1.074 0.0689 -0.741 34.107 
WC 0.445 0.198 0.922 0.296 0.0293 6.528 62.028 
* Skewness. * *Kurotsis. 
A regression model, however, requires that error be randomly distributed 
about the regression function. Examination of residuals showed that they 
were not so distributed as a number of cases fell well away from predicted 
values. These values represent families which are used much more, or much 
less, than availability would predict; in other words, these values represent 
families in which selectivity is apparent. An attempt was then made to sort 
out these highly selected families, and to re-examine those remaining. 
To do this, families were sorted into strata as a function of the number 
of standard deviations by which observed medicinal uses differed from pre- 
dicted uses. Stratum 1 included all plant families with residuals two standard 
deviations below predicted value, stratum 2 all those between one and two 
standard deviations below predicted value, stratum 3 all those within one 
standard deviation of the predicted value; strata 4 and 5 match strata 1 and 2 
above the mean. In this way, plant families with usage above and below that 
level which would be predicted by generic and specific availability could be 
identified; alternatively, this technique identified those families in which 
substantial selectivity in usage (positive or negative) was indicated. Table 3 
lists two groups of plant families, those used much more or much less fre- 
quently than one would predict on the basis of generic and specific availability. 
These data were then put to another test. The families which indicated 
substantial selectivity were deleted from the sample, and the regressions were 
repeated (see Table 4). In four of five regions, this procedure “improved” 
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TABLE 3 
Family Strata (see text) Mean 
NA NC SW IM WC 



































5 5 5 5 5 5 
5 5 5 5 3 4.6 
5 5 3 5 5 4.6 
4 3 5 5 3 4 
4 4 3 3 5 3.8 
4 5 3 3 4 3.8 
4 4 3 3 5 3.8 
4 5 3 3 3 3.6 
3 5 2 3 5 3.6 
4 4 3 3 4 3.6 
4 3 1 5 4 3.4 
4 3 3 4 3 3.4 
3 3 4 4 3 3.4 
4 4 3 3 3 3.4 
3 4 3 3 3 3.2 
3 4 3 3 3 3.2 
3 4 3 3 3 3.2 
3 3 3 4 3 3.2 
3 3 3 3 4 3.2 
3 3 4 3 3 3.2 
3 3 4 3 3 3.2 
3 3 4 2 3 3.0 
3 3 2 3 3 2.8 
3 3 3 2 3 2.8 
3 3 2 3 3 2.8 
3 3 3 2 2 2.6 
2 3 2 3 3 2.6 
3 3 2 2 3 2.6 
2 2 3 2 2 2.2 
1 2 3 2 2 2 
2 1 3 1 2 1.8 
I 1 3 1 2 1.8 
1 1 1 1 1 1 
the regression results, particularly for Western Canada, where r increased 
from 0.445 to 0.893. In the Intermountain region, the correlation dropped 
slightly from 0.805 to 0.777. In all cases, the residuals assumed a more 
normal distribution. Kurtosis dropped at least by a factor of 6 in all cases. 
But these residuals are by no means yet in a random distribution. We infer 
that substantial selectivity continues to be in evidence, even after reducing 
sample size by deleting those families showing the most selectivity. 
To test the hypothesis in another way, a similar stratifying procedure 
was used on the entire North American sample for which figures were 
available for the actual numbers of genera and species with medicinal uses 
per family. Single regressions were calculated for medicinal genera on 
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TABLE 4 
Multiple regressions: number of medicinal items per family regressed on number of genera 
and number of species per family, for North America and four selected regions, deleting 
families showing substantial selectivity 
- 
Region n Multiple Coef. of Constant Regression coefficients Residuals 
correlation determination 
(r) (r2) 
Genera Species S* K** 
NA 214 0.815 0.664 0.699 0.547 0.140 1.679 6.321 
NC 214 0.802 0.643 -0.032 0.481 0.104 0.830 3.233 
SW 218 0.925 0.855 0.571 1.055 -0.052 0.338 4.846 
IM 215 0.777 0.604 -0.243 0.708 0.082 i.990 7.317 
WC 216 0.893 0.798 0.068 0.188 0.076 2.219 9.369 
- 
*Skewness. **Kurtosis. 
available genera, and medicinal species on available species; in both cases 
correlations were high, 0.895 and 0.849 respectively. The first case was 
selected for further analysis. Examination of residuals showed a highly 
“spiked” distribution (kurtosis = 59.7), mean of zero, and modest skewing 
(skewness = -3.97). Families showing substantial “error”, that is, positive 
or negative selectivity relative to availability, were deleted from the sample, 
and the remaining cases were again subjected to regression. Cases were drop- 
ped in which the actual value departed from the predicted value by more 
(or less) than the value of the standard error in the previous regression. Fol- 
lowing each regression, the distribution of the reduced number of residuals 
was examined, families with residuals greater than one standard error were 
dropped, and the regression was repeated. By the third iteration, residual 
distribution began to approximate more closely a normal distribution. Sample 
size was by then 210 (from 232), mean was zero, skewness was reduced to 
0.296, kurtosis to 0.174. While residuals formed a ragged bell shape, 67% of 
cases fell within one standard deviation of the mean, and 95% within two. 
Statistics for these three regressions (plus a fourth) appear in Table 5. The 
TABLE 5 
Successive regressions of medicinal genera on available genera, dropping cases with sub- 
stantial error 




Min. Max. Skewness Kurtosis 
1 232 0.89456 8.6059 -31.237 15.196 -3.973 59.693 
2 228 0.91952 2.1799 -8.4393 8.4393 0.254 10.402 
3 210 0.92132 0.69697 -1.9053 2.2203 0.296 0.174 
4 134 0.96573 0.0926 -0.4719 0.74652 1.059 0.990 
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twenty-two plant families deleted in the first three iterations are listed in 
Table 6. The 76 families (31 “low use”, 45 “high use”) dropped for the last 
iteration are not listed. 
Discussion 
There are obviously a number of substantial methodological flaws in 
this paper. Ethnological data on which AME is based were gathered by many 
investigators, some with dubious botanical qualification, over a period of 
80 years; many of their identifications are probably suspect. Many botanists 
would disagree with aspects of the taxonomy in FNA. Moreover, the presence 
of plants representing a taxon in a region is not a very precise measure of 
their availability (e.g., compare the availability in the Great Lakes area of 
Taraxacum officinale with, say, that of Malaxis paludosa). Again, if for 
half of the North American plant families medicinal usage approximates 
availability, this may be because medicinal value is randomly distributed 
among the taxa of these families. 
Yet this approach yields dividends. While general knowledge of ethno- 
botany would surely pick out Asteraceae and Rosaceae as worthy of special 
notice, it seems less obvious to identify Caprifoliaceae, with its 7 genera 
and 77 species, as a particularly “medicinal” family; yet all seven genera are 
used medicinally (105 ways) by the AME sample of cultures. 
TABLE 6 
Highest and lowest use families identified by subsequent regressions of medicinal genera 

















2 Pinaceae 8.3955 Orchidaceae -7.5856 
Fabaceae 7.4955 Acanthaceae -4.1883 
Caprifoliaceae 5.3955 Caryophyllaceae -3.6334 
Lamiaceae 4.8450 Rubiaceae -3.2027 
Liliaceae 4.1991 Sapindaceae -2.6811 
Apiaceae 3.8928 Myrticaceae -2.2505 





*On initial regression. 
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Also of interest is the number of “low use” families from Table 3 which 
contain widely used food species: Poaceae (Gramineae), Brassicaceae (Cruci- 
ferae), Fabaceae (Leguminosae), Cucurbitaceae, and Chenopodiaceae are all 
families of widely used food plants. While some families in the “high use” 
portion of Table 3 provide edibles (sunflower seeds, pine nuts), most do not. 
Food and medicine appear by this analysis to be substantially discontinuous 
categories. 
Conclusions 
It is clear that much of medicine (ethno- or otherwise) is symbolic, 
based on meaning and placebo. But these data indicate substantial selectivity 
in the medical use of natural species by native American peoples. The three 
highest use families from Table 6 (Asteraceae, Rosaceae, Ranunculaceae) 
account for 29% of medicinal items in AME, but 15.9% of genera in FNA, 
while the three lowest use families from that Table (Poaceae, Orchidaceae, 
Acanthaceae) account for 1.2% of items in AME, but 12% of genera in FNA. 
Evidently, native American medical ethnobotany was not “only placebo 
medicine”. 
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